Exact Sciences Stock Current Valuation
| EXAS Stock | USD 63.48 0.26 0.41% |
Valuation analysis of EXACT Sciences helps investors to measure EXACT Sciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to gain to about 370.1 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (1.1 K). Fundamental drivers impacting EXACT Sciences' valuation include:
Price Book 4.1191 | Enterprise Value 13.3 B | Enterprise Value Ebitda 503.1228 | Price Sales 5.1807 | Enterprise Value Revenue 5.8937 |
Undervalued
Today
Please note that EXACT Sciences' price fluctuation is very steady at this time. Calculation of the real value of EXACT Sciences is based on 3 months time horizon. Increasing EXACT Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for EXACT Sciences is useful when determining the fair value of the EXACT stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of EXACT Sciences. Since EXACT Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EXACT Stock. However, EXACT Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 63.48 | Real 74.42 | Target 106.38 | Hype 63.36 | Naive 55.99 |
The real value of EXACT Stock, also known as its intrinsic value, is the underlying worth of EXACT Sciences Company, which is reflected in its stock price. It is based on EXACT Sciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of EXACT Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EXACT Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EXACT Sciences helps investors to forecast how EXACT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EXACT Sciences more accurately as focusing exclusively on EXACT Sciences' fundamentals will not take into account other important factors: EXACT Sciences Company Current Valuation Analysis
EXACT Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current EXACT Sciences Current Valuation | 13.31 B |
Most of EXACT Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EXACT Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
EXACT Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for EXACT Sciences is extremely important. It helps to project a fair market value of EXACT Stock properly, considering its historical fundamentals such as Current Valuation. Since EXACT Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EXACT Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EXACT Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
EXACT Current Valuation Historical Pattern
Today, most investors in EXACT Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various EXACT Sciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of EXACT Sciences current valuation as a starting point in their analysis.
EXACT Sciences Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, EXACT Sciences has a Current Valuation of 13.31 B. This is 7.32% lower than that of the Biotechnology sector and 70.75% higher than that of the Health Care industry. The current valuation for all United States stocks is 19.92% higher than that of the company.
EXACT Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXACT Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics of similar companies.EXACT Sciences is currently under evaluation in current valuation category among related companies.
EXACT Fundamentals
| Return On Equity | -0.066 | ||||
| Return On Asset | -0.0304 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 13.31 B | ||||
| Shares Outstanding | 181.53 M | ||||
| Shares Owned By Insiders | 1.00 % | ||||
| Shares Owned By Institutions | 89.38 % | ||||
| Number Of Shares Shorted | 6.34 M | ||||
| Price To Earning | (38.17) X | ||||
| Price To Book | 4.12 X | ||||
| Price To Sales | 5.18 X | ||||
| Revenue | 2.5 B | ||||
| Gross Profit | 1.51 B | ||||
| EBITDA | (13.13 M) | ||||
| Net Income | (204.15 M) | ||||
| Cash And Equivalents | 728.04 M | ||||
| Cash Per Share | 4.11 X | ||||
| Total Debt | 2.55 B | ||||
| Debt To Equity | 0.77 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | 17.34 X | ||||
| Cash Flow From Operations | 156.12 M | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | (1.13) X | ||||
| Price To Earnings To Growth | (1.07) X | ||||
| Target Price | 90.66 | ||||
| Number Of Employees | 6.5 K | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 11.52 B | ||||
| Total Asset | 6.47 B | ||||
| Retained Earnings | (3.47 B) | ||||
| Working Capital | 679.67 M | ||||
| Current Asset | 325.86 M | ||||
| Current Liabilities | 26.72 M | ||||
| Net Asset | 6.47 B |
About EXACT Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXACT Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
EXACT Sciences Investors Sentiment
The influence of EXACT Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in EXACT. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to EXACT Sciences' public news can be used to forecast risks associated with an investment in EXACT. The trend in average sentiment can be used to explain how an investor holding EXACT can time the market purely based on public headlines and social activities around EXACT Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
EXACT Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for EXACT Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average EXACT Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on EXACT Sciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EXACT Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EXACT Sciences' short interest history, or implied volatility extrapolated from EXACT Sciences options trading.
Pair Trading with EXACT Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against EXACT Stock
| 0.69 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.49 | KZR | Kezar Life Sciences Financial Report 9th of May 2024 | PairCorr |
| 0.46 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.41 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out EXACT Sciences Piotroski F Score and EXACT Sciences Altman Z Score analysis. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 13.876 | Quarterly Revenue Growth 0.17 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.